Nath Bio-Genes (India) Limited (BOM:537291)

India · Delayed Price · Currency is INR

165.30

+1.75 (1.07%)

At close: Jul 13, 2026

-26.76% (1Y)

Market Cap	3.08B -18.2%
Revenue (ttm)	4.45B +21.9%
Net Income	416.30M +7.9%
EPS	20.98 +3.3%
Shares Out	n/a
PE Ratio	7.40
Forward PE	n/a
Dividend	2.00 (1.21%)
Ex-Dividend Date	Aug 14, 2025

Volume	360
Open	163.55
Previous Close	163.55
Day's Range	163.55 - 165.30
52-Week Range	126.75 - 238.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jowar; and seeds for vegetables comprising chilli, okra, tomato, bitter gourd, and cucumber. It also provides crop protection supplements under the Win-ch... [Read more]

Industry Agricultural Production Crops

Founded 1979

Employees 451

Stock Exchange Bombay Stock Exchange

Ticker Symbol 537291

Full Company Profile

Financial Performance

In fiscal year 2026, Nath Bio-Genes (India)'s revenue was 4.45 billion, an increase of 21.93% compared to the previous year's 3.65 billion. Earnings were 416.30 million, an increase of 7.85%.

Financial Statements